Plasma metabolomics and clinical predictors of survival differences in COPD patients

BACKGROUND: Plasma metabolomics profile (PMP) in COPD has been associated with clinical characteristics, but PMP’s relationship to survival has not been reported. We determined PMP differences between patients with COPD who died an average of 2 years after enrollment (Non-survivors, NS) compared to...

Descripción completa

Detalles Bibliográficos
Autores principales: Pinto-Plata, Victor, Casanova, Ciro, Divo, Miguel, Tesfaigzi, Yohannes, Calhoun, Vince, Sui, Jing, Polverino, Francesca, Priolo, Carmen, Petersen, Hans, de Torres, Juan Pablo, Marin, Jose Maria, Owen, Caroline A., Baz, Rebeca, Cordova, Elizabeth, Celli, Bartolome
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2019
Materias:
Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6794856/
https://www.ncbi.nlm.nih.gov/pubmed/31615518
http://dx.doi.org/10.1186/s12931-019-1167-y

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6794856/
https://www.ncbi.nlm.nih.gov/pubmed/31615518
http://dx.doi.org/10.1186/s12931-019-1167-y

Ejemplares similares